🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Several experts said the demand for retatrutide could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on TikTok, the service has removed violative material and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.

Within moments of joining one community, a vendor shared contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, posts show black plastic packages with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it regularly monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has already encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to potentially significant medical dangers”.